231 related articles for article (PubMed ID: 28328867)
1. Astragaloside IV Alleviates Lipopolysaccharide-Induced Acute Kidney Injury Through Down-Regulating Cytokines, CCR5 and p-ERK, and Elevating Anti-Oxidative Ability.
Zhou W; Chen Y; Zhang X
Med Sci Monit; 2017 Mar; 23():1413-1420. PubMed ID: 28328867
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
[TBL] [Abstract][Full Text] [Related]
3. CCR5 deficiency increased susceptibility to lipopolysaccharide-induced acute renal injury.
Lee DH; Park MH; Hwang CJ; Hwang JY; Yoon HS; Yoon DY; Hong JT
Arch Toxicol; 2016 May; 90(5):1151-62. PubMed ID: 26055553
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV Alleviates the Myocardial Damage Induced by Lipopolysaccharide via the Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB)/Proliferator-Activated Receptor α (PPARα) Signaling Pathway.
Zhang X; Li M; Wang H
Med Sci Monit; 2019 Sep; 25():7158-7168. PubMed ID: 31545785
[TBL] [Abstract][Full Text] [Related]
5. The Nephroprotective Effect of MS-275 on Lipopolysaccharide (LPS)-Induced Acute Kidney Injury by Inhibiting Reactive Oxygen Species (ROS)-Oxidative Stress and Endoplasmic Reticulum Stress.
Zhang H; Zhang W; Jiao F; Li X; Zhang H; Wang L; Gong Z
Med Sci Monit; 2018 Apr; 24():2620-2630. PubMed ID: 29704392
[TBL] [Abstract][Full Text] [Related]
6. Esculentoside A inhibits LPS-induced acute kidney injury by activating PPAR-γ.
Chen DZ; Chen LQ; Lin MX; Gong YQ; Ying BY; Wei DZ
Microb Pathog; 2017 Sep; 110():208-213. PubMed ID: 28666844
[TBL] [Abstract][Full Text] [Related]
7. Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress.
Ji C; Luo Y; Zou C; Huang L; Tian R; Lu Z
BMC Pharmacol Toxicol; 2018 Sep; 19(1):53. PubMed ID: 30176914
[TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis.
Zhao YL; Zhang L; Yang YY; Tang Y; Zhou JJ; Feng YY; Cui TL; Liu F; Fu P
Chin Med J (Engl); 2016 May; 129(9):1100-7. PubMed ID: 27098797
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.
Gui D; Huang J; Liu W; Guo Y; Xiao W; Wang N
Apoptosis; 2013 Apr; 18(4):409-22. PubMed ID: 23325448
[TBL] [Abstract][Full Text] [Related]
10. Licochalcone A Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting NF-κB Activation.
Hu J; Liu J
Inflammation; 2016 Apr; 39(2):569-74. PubMed ID: 26552405
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced acute kidney injury in a rat model of sepsis.
Liu L; Song Y; Zhao M; Yi Z; Zeng Q
Int Urol Nephrol; 2015 Oct; 47(10):1745-52. PubMed ID: 26300162
[TBL] [Abstract][Full Text] [Related]
12. Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats.
Shimokawa T; Yoneda K; Yamagata M; Hayashi K; Tomita S
Eur J Pharmacol; 2020 Mar; 871():172917. PubMed ID: 31935395
[TBL] [Abstract][Full Text] [Related]
13. Zingerone ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting Toll-like receptor 4 signaling pathway.
Song J; Fan HJ; Li H; Ding H; Lv Q; Hou SK
Eur J Pharmacol; 2016 Feb; 772():108-14. PubMed ID: 26698392
[TBL] [Abstract][Full Text] [Related]
14. Suppression of mitochondrial biogenesis through toll-like receptor 4-dependent mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling in endotoxin-induced acute kidney injury.
Smith JA; Stallons LJ; Collier JB; Chavin KD; Schnellmann RG
J Pharmacol Exp Ther; 2015 Feb; 352(2):346-57. PubMed ID: 25503387
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D3 pretreatment alleviates renal oxidative stress in lipopolysaccharide-induced acute kidney injury.
Xu S; Chen YH; Tan ZX; Xie DD; Zhang C; Xia MZ; Wang H; Zhao H; Xu DX; Yu DX
J Steroid Biochem Mol Biol; 2015 Aug; 152():133-41. PubMed ID: 26013770
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV attenuates inflammatory injury and promotes odontoblastic differentiation in lipopolysaccharide-stimulated MDPC-23 cells and rat pulpitis.
Ding Q; Gao J; Zheng J; Wang A; Jing S
J Oral Pathol Med; 2019 Nov; 48(10):951-958. PubMed ID: 31318999
[TBL] [Abstract][Full Text] [Related]
17. Protective Effect of Astragaloside IV Against Paraquat-Induced Lung Injury in Mice by Suppressing Rho Signaling.
Chen T; Wang R; Jiang W; Wang H; Xu A; Lu G; Ren Y; Xu Y; Song Y; Yong S; Ji H; Ma Z
Inflammation; 2016 Feb; 39(1):483-492. PubMed ID: 26452991
[TBL] [Abstract][Full Text] [Related]
18. The inflammatory response in blood and in remote organs following acute kidney injury.
Brøchner AC; Dagnaes-Hansen F; Højberg-Holm J; Toft P
APMIS; 2014 May; 122(5):399-404. PubMed ID: 24033773
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules.
Li M; Qu YZ; Zhao ZW; Wu SX; Liu YY; Wei XY; Gao L; Gao GD
Neurochem Int; 2012 Apr; 60(5):458-65. PubMed ID: 22342823
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy.
Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G
J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
